| Main purpose |
Provide broad gut health insights and translate results into nutrition and supplement recommendations. |
Provide a gut microbiome test with interpretation and guidance based on its own reporting approach. |
| Best for |
People who want a consumer-friendly report and detailed, food-item level personalization. |
People who want the competitor’s microbiome profiling and interpretation format for gut insights. |
| Sample type |
Stool sample. |
Stool sample. |
| Analysis method |
Uses 16S DNA sequencing and shotgun metagenomics within its Gut Health Operating System. |
Profiling method depends on Biopolis’ test offering; typically DNA-based sequencing on stool. |
| What it measures |
Gut microbiome ecosystem features that can be linked to broad gut health and personalization. |
Gut microbiome composition and related markers as defined by the test protocol. |
| Pathogens included? |
Unclear from the provided information; depends on how InnerBuddies defines pathogen reporting in its results. |
Unclear from the provided information; depends on Biopolis’ specific report scope. |
| Functional / microbiome balance insight |
Includes functional/balance-oriented interpretation as part of its operating system approach. |
Likely includes balance/composition interpretation, but the exact functional angle depends on the Biopolis report. |
| Broad gut health overview |
Explicitly designed to provide a broad overview of gut health. |
Provides gut health interpretation, though depth and framing depend on the specific offering. |
| Personalized recommendations |
Nutrition and supplements personalized using both stool results and a 3-day food diary. |
Personalized guidance based on the microbiome findings and their interpretation model. |
| Nutrition guidance included |
Yes—includes personalized food diary-driven guidance, including individual food items and daily dosage. |
Often includes nutrition-related guidance, but item-level dosage detail may vary. |
| Actionability of results |
High: actionable suggestions linked to the user’s food diary and sequencing results. |
Actionability depends on how detailed the recommendations are in the Biopolis report. |
| Easy-to-understand report |
Yes—consumer-friendly and easy to understand. |
Varies by reporting style; may be more clinical or more technical depending on the product. |
| Consumer-friendly vs clinician-focused |
Consumer-focused with plain-language interpretation. |
Unknown from provided details; could be either depending on their default report design. |
| Suitable for ongoing monitoring |
Yes—sequencing-based profiling supports longitudinal comparisons over time. |
Typically suitable for repeat testing if the workflow and reporting are standardized. |
| Turnaround time |
Unspecified in the provided information. |
Unspecified in the provided information. |
| Price |
Unspecified in the provided information. |
Unspecified in the provided information. |
| Available in Europe / direct-to-consumer |
Available in Europe and direct-to-consumer. |
Unclear from provided information; availability depends on Biopolis’ market coverage. |
| Data privacy / EU friendliness |
EU-oriented direct-to-consumer operation is implied; specific privacy terms not provided here. |
EU friendliness depends on Biopolis’ data handling and legal framework; not provided here. |